Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.070
+0.040 (3.88%)
At close: May 26, 2026, 4:00 PM EDT
1.060
-0.010 (-0.93%)
After-hours: May 26, 2026, 7:33 PM EDT
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $99.55 million as of May 26, 2026. Its market cap has increased by 153.59% in one year.
Market Cap
99.55M
Enterprise Value
96.40M
1-Year Change
153.59%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.87M to $99.55M, a decrease of -37.34%. That is a compound annual growth rate of -5.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 99.55M | 226.48% |
| Dec 31, 2025 | 30.49M | -38.81% |
| Dec 31, 2024 | 49.83M | 234.56% |
| Dec 29, 2023 | 14.89M | 38.39% |
| Dec 30, 2022 | 10.76M | -78.89% |
| Dec 31, 2021 | 50.98M | 20.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 99.05M |
| ProMIS Neurosciences | 98.47M |
| Q32 Bio | 98.35M |
| LeonaBio | 97.04M |
| PolyPid | 95.80M |
| Annovis Bio | 94.87M |
| Oncolytics Biotech | 94.01M |
| Anixa Biosciences | 93.54M |